Skip to main content

How can we help you?

  • Deal or case news
  • 28-08-2023

NautaDutilh assisted an ad hoc group of lenders with the Luxembourg aspects of the cross-border financial recapitalisation of Swiss multinational specialty pharmaceutical company Covis Pharma.

On April 2023, Covis Pharma announced that it had entered into a restructuring support agreement. A few weeks later, the transaction resulted in Apollo retaining a majority ownership in the reorganised Covis Pharma, while the ad hoc group of first lien lenders received a substantial minority equity stake, in addition to the restructured first lien debt.

Romain Sabatier commented: “We are honoured to have assisted on this important restructuring that will enable Covid Pharma to be operationally and financially in a position to scale its business and the lenders to remain whole.”

Next to Romain, the team consisted of Jean-Marc Groelly (tax partner), Max Heuermann and Audrey Derep. Our team worked alongside the U.S. team of Weil, Gotshal & Manges LLP.

Cookie notice

We care about your privacy. We only use cookies strictly necessary to ensure the proper functioning of our website. You can find more information on cookies and on how we handle your personal data in our Privacy and Cookie Policy.